Saturday, 30 May 2020

Drugs standards group nixes plan to kick pharma's crab blood habit

Horseshoe crabs' icy-blue blood is set to remain the drug industry's standard for safety tests after a powerful U.S. group ditched a plan to put on an equal footing a synthetic substitute pushed by Swiss biotech Lonza and animal welfare groups.


from Reuters: Health News https://ift.tt/36JwPt3

No comments:

Post a Comment